SG30569G - Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents - Google Patents

Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents

Info

Publication number
SG30569G
SG30569G SG1995904462A SG1995904462A SG30569G SG 30569 G SG30569 G SG 30569G SG 1995904462 A SG1995904462 A SG 1995904462A SG 1995904462 A SG1995904462 A SG 1995904462A SG 30569 G SG30569 G SG 30569G
Authority
SG
Singapore
Prior art keywords
magnetic resonance
nuclear magnetic
contrast agents
resonance imagery
dipyridoxyl
Prior art date
Application number
SG1995904462A
Other languages
English (en)
Inventor
Scott M Rocklage
Steven C Quay
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Publication of SG30569G publication Critical patent/SG30569G/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Signal Processing (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1995904462A 1987-05-08 1988-05-06 Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents SG30569G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/047,614 US4933456A (en) 1987-05-08 1987-05-08 Dipyridoxyl phosphate NMRI contrast agents

Publications (1)

Publication Number Publication Date
SG30569G true SG30569G (en) 1995-09-18

Family

ID=21949962

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995904462A SG30569G (en) 1987-05-08 1988-05-06 Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents

Country Status (20)

Country Link
US (1) US4933456A (de)
EP (1) EP0290047B1 (de)
JP (1) JP2512524B2 (de)
AR (1) AR246956A1 (de)
AT (1) ATE118010T1 (de)
AU (1) AU613363B2 (de)
BR (1) BR1100623A (de)
CA (1) CA1322003C (de)
DE (2) DE19775088I2 (de)
DK (1) DK173849B1 (de)
ES (1) ES2066768T3 (de)
FI (1) FI88164C (de)
GR (1) GR3015884T3 (de)
HK (1) HK55195A (de)
IE (1) IE66368B1 (de)
IL (1) IL86298A (de)
NL (1) NL970040I2 (de)
NO (2) NO177462C (de)
NZ (1) NZ224537A (de)
SG (1) SG30569G (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4994259A (en) * 1987-05-08 1991-02-19 Salutar, Inc. Improvement in the method of NMR imaging employing a manganese II chelates of N,N'-bis[pyridoxal-alkylene (or cycloalkylene) (or arylene)]-N,N'-diacetic acid derivatives
US4827426A (en) * 1987-05-18 1989-05-02 The Coca-Cola Company Data acquisition and processing system for post-mix beverage dispensers
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
AU7346091A (en) * 1990-03-02 1991-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparations for mr diagnosis
JPH06500090A (ja) * 1990-08-15 1994-01-06 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 錯塩の新規使用
DE4026103A1 (de) * 1990-08-17 1992-02-20 Byk Gulden Lomberg Chem Fab Neue verwendung von komplexsalzen
AU1154292A (en) * 1991-01-07 1992-08-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Contrast agents for magnetic-resonance imaging
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
US5312617A (en) * 1991-05-23 1994-05-17 Unger Evan C Liposoluble compounds useful as magnetic resonance imaging agents
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
TW319763B (de) 1995-02-01 1997-11-11 Epix Medical Inc
SG81898A1 (en) * 1995-08-11 2001-07-24 Sumitomo Chemical Co Olefin polymerization catalyst component, olefin polymerization catalyst and process for producing olefin polymer
US6005083A (en) * 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
ATE381352T1 (de) * 1997-07-01 2008-01-15 Ge Healthcare As Diagnostisches verfahren zum nachweis von myokard-ischämie
DE69826528T2 (de) * 1997-12-23 2006-02-23 Amersham Health As Stickstoffoxid freisetzende chelatbildner und ihre therapeutische verwendung
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
AU2012364227B2 (en) * 2012-01-05 2017-12-07 Egetis Therapeutics Ab Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632637A (en) * 1968-02-13 1972-01-04 Arthur E Martell Hydroxyaryl-containing aminocarboxylic chelating agents
AU485693B2 (en) * 1973-08-24 1976-02-05 The Council Ofthe Institute Of Medical And Veterinary Science, Andthe Universityof Adelaide Gariti Cancer Foundation New radiopharmaceuticals for cholescintigraphy
JPS5569517A (en) * 1978-11-20 1980-05-26 Nippon Mejifuijitsukusu Kk Labelling preparation for labelling of erythrocytes with radio-active technetium
JPS5791927A (en) * 1980-11-27 1982-06-08 Nippon Mejifuijitsukusu Kk Technetium-99m labelled diagnosticum
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US4842845A (en) * 1987-05-08 1989-06-27 Salutar, Inc. Radioactive metal chelates for dipyridoxyl phosphate
US4935518A (en) 1987-05-08 1990-06-19 Salutar, Inc. Manganese(II), chelate contrast agents derived from N,N'-bis-(pyridoxal ethylene diamine-N,N')-diacetic acid and derivatives thereof

Also Published As

Publication number Publication date
DE19775088I2 (de) 2001-05-23
DK251688D0 (da) 1988-05-06
FI882125A0 (fi) 1988-05-06
CA1322003C (en) 1993-09-07
AU613363B2 (en) 1991-08-01
NL970040I2 (nl) 1998-06-02
IL86298A0 (en) 1988-11-15
NO1998004I1 (no) 1998-01-19
NO177462B (no) 1995-06-12
US4933456A (en) 1990-06-12
AR246956A1 (es) 1994-10-31
NO882004D0 (no) 1988-05-06
IE66368B1 (en) 1995-12-27
EP0290047A2 (de) 1988-11-09
FI88164C (fi) 1993-04-13
HK55195A (en) 1995-04-21
NZ224537A (en) 1991-06-25
NO882004L (no) 1988-11-09
ATE118010T1 (de) 1995-02-15
FI882125A7 (fi) 1988-11-09
IE881366L (en) 1988-11-08
GR3015884T3 (en) 1995-07-31
EP0290047B1 (de) 1995-02-01
JPS63280087A (ja) 1988-11-17
DK251688A (da) 1988-11-09
AU1568088A (en) 1988-11-10
FI88164B (fi) 1992-12-31
JP2512524B2 (ja) 1996-07-03
NL970040I1 (nl) 1998-02-02
DE3852906T2 (de) 1995-06-22
DE3852906D1 (de) 1995-03-16
ES2066768T3 (es) 1995-03-16
NO177462C (no) 1995-09-20
EP0290047A3 (en) 1990-04-25
IL86298A (en) 1992-11-15
DK173849B1 (da) 2001-12-27
BR1100623A (pt) 1999-12-07

Similar Documents

Publication Publication Date Title
EP0290047A3 (en) Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents
EP0240319A3 (en) Magnetic resonance imaging system
GB2140569B (en) Nuclear magnetic resonance imaging
EP0412824A3 (en) Magnetic resonance imaging system
DE3570924D1 (en) Nuclear magnetic resonance tomograph
GB2157832B (en) Nuclear magnetic resonance imaging
DE3569614D1 (en) Magnetic resonance imaging system
GB8528357D0 (en) Nuclear magnetic resonance imaging
GB2148013B (en) Nuclear magnetic resonance imaging
GB8813425D0 (en) Magnetic resonance imaging
GB2150302B (en) Nuclear magnetic resonance imaging
EP0204320A3 (en) Magnetic resonance imaging method
IL76398A (en) Magnetic resonance imaging
GB2234594B (en) Nuclear magnetic resonance imaging methods
DE3666632D1 (en) Nuclear magnetic resonance imaging method
GB2201794B (en) Magnetic resonance imaging system
EP0208522A3 (en) Nuclear magnetic resonance system
DE3574055D1 (en) Nuclear magnetic resonance imaging
EP0335981A4 (de) Magnetisches resonanzbildsystem.
EP0139102A3 (en) Nuclear magnetic resonance imaging system
GB8521791D0 (en) Nuclear magnetic resonance imaging
GB2162641B (en) Nuclear magnetic resonance
GB2234595B (en) Nuclear magnetic resonance imaging methods
GB8611963D0 (en) Nuclear magnetic resonance
GB2182451B (en) Nuclear magnetic resonance imaging